E-cadherin, a member of the cadherin family of transmembrane adhesion receptors, is critical for cutaneous barrier function, as it promotes keratinocyte and Langerhans cell adhesion in the epidermis. Recent murine models of chronic inflammation identified new E-cadherin expressing subsets of mononuclear phagocytes, including alternatively activated macrophages and selected inflammatory dendritic cells. It has been shown in vitro that expression of E-cadherin by murine macrophages promotes their homotypic aggregation and fusion to multinucleated giant cells (MNGCs), a signature cell type of granulomatous inflammation. The purpose of this study was to assess E-cadherin expression on histiocytes and giant cells in cutaneous granulomas in humans. E-cadherin expression was evaluated by immunohistochemistry of formalin-fixed paraffin-embedded skin biopsies of foreign body granulomas (n = 21) and sarcoidosis (n = 21). The results showed consistent membranous E-cadherin staining pattern on mononucleated histiocytes and MNGCs in both granuloma types. These E-cadherin expressing histiocytes are distinct from dermal Langerhans cells because they lacked CD1a expression. Our findings suggest that E-cadherin expressing mononuclear histiocytes are likely precursors for MNGCs in cutaneous granulomas and may play a critical role in disease pathogenesis.
INTRODUCTION
Chronic granulomatous inflammation in the skin is characterized by the tight aggregation of dermal mononuclear phagocytes and multinucleated giant cells (MNGCs), which are thought to encapsulate and prevent the systemic spread of hard-to-eradicate microorganisms, such as mycobacteria, selected fungi, or helminths. 1 Granuloma formation is also a hallmark of noninfectious cutaneous disorders. Foreign body granulomatous reaction (FBGR) is designed to isolate foreign particles, including splinters, sutures, and keratin fragments, released from ruptured cysts or hair follicles. Sarcoidosis is a multisystem inflammatory disorder in which epithelioid macrophages and dendritic cells (DCs) aggregate into granulomas, likely in response to poorly characterized antigens. 2 Multiple innate and adaptive immune pathways have been implicated in the pathogenesis of granulomatous inflammation. Most granulomas, including sarcoidosis, are driven by proinflammatory cytokines such as tumor necrosis factor (TNF)-a and T helper (TH)-1 cytokines, including interferon (IFN)-g. 3 In the pathogenesis of sarcoidal granulomas, IFN-gactivated macrophages (classically activated), and DCs are thought to play a central role. More recently, increased levels of interleukin (IL)-17A, IL-22, and IL-23 have been observed in the blood and tissue of sarcoidosis patients, indicating a potential role for the (TH)-17 immune pathway in disease pathogenesis. 4 In contrast to sarcoidal granulomas, FBGR is dependent on innate cell-derived IL-4 as evidenced by the impairment of FBGR by blocking IL-4 antibodies in vivo but by the preservation of this response in T-cell deficient animals. 5, 6 Based on these observations, it is inferred that FBGR is dependent on IL-4-activated macrophages and/or DCs, which are also referred to as alternatively activated macrophages or DCs (AAMacs or AADCs, respectively). 7, 8 MNGCs are the hallmark feature of granulomas. In FBGR, foreign-body-type giant cells are formed by IL-4-dependent fusion of AAMacs and/or AADCs. 9 In sarcoidal granulomas, the presence of FB-type giant cells are likely the products of IL-4 or IL-13-dependent cell-cell fusion, whereas other MNGCs are possibly formed through IFN-g/IL17-dependent fusion pathways. 4, 10 E-cadherin, an epithelial cadherin, is critical in epidermal barrier function by regulating the formation of tight junctions between keratinocytes. 11 E-cadherin expression has also been observed in CD1a + Langerhans cells (LCs) in the epidermis, where it is thought to enhance heterotypic adhesion between LCs and keratinotyes. 12 E-cadherin is upregulated in IL-4/IL-13-activated macrophages and promotes the homotypic aggregation and fusion of these cells. 13, 14 Furthermore, a novel subset of murine inflammatory DCs expressing E-cadherin has been recently identified with TH17 promoting potential in inflammatory colitis. 15 The contribution of E-cadherin expressing mononuclear phagocytes to human inflammatory conditions, including granulomatous inflammation, is not known. Here, we evaluated whether E-cadherin is expressed by histiocytes within cutaneous foreign body and sarcoidal granulomas.
MATERIALS AND METHODS

Patient Selection
After Institutional Review Board approval, archived skin biopsies representing cutaneous foreign body granuloma (n = 21) and sarcoidosis (n = 21) were reviewed and selected for our study by 2 board-certified dermatopathologists at the Penn Cutaneous Pathology Service.
Immunohistochemical Staining
Immunohistochemistry of formalin-fixed paraffinembedded tissue sections (4 mm) was performed to determine E-cadherin expression on a Leica Bond immunostaining platform using a brown chromogen indicator (Diaminobenzidine) against a hematoxylin counterstain using the Bond Polymer Refine Detection System. Samples were rehydrated in xylene (3 times), 95% ethanol, and 75% ethanol. Heatinduced epitope retrieval was done for 20 minutes with ER2 solution (Leica Microsystems AR9640). Antibodies against E-cadherin (Dako, Carpinteria, CA; M3612) were used at a 1:10 dilution. Antibodies against CD1a (Dako; M3571) at 1:50 dilution, pan-CK (BioGenex, Freemont, CA; MU357-UC) at 1:75 dilution, and AE1/AE3 (Leica, Buffalo Grove, IL; #NCL-L-AE1/AE3) at 1:100 dilution were used. For negative controls, either an isotyped-matched control primary antibody was used or the primary antibody was omitted from the staining protocol.
RESULTS
Hematoxylin and eosin-stained sections demonstrated FBGR at sites of follicular rupture (n = 2; Figs. 1A, B).
[Epidermal inclusion cyst rupture (n = 6, not shown), scar and granulomatous inflammation (n = 9, not shown), reactions to nonsuture polarizable foreign material (n = 3, not shown), and suture granuloma (n = 1, not shown).] Immunohistochemical staining for E-cadherin showed strong staining in the epidermis, hair follicles, eccrine ducts, and cyst wall epithelium (Figs. 1C, D) . At low power, there was weaker but significant E-cadherin staining on granuloma-associated histiocytes and MNGCs in 20 (95%)/21 cases studied (Figs. 1C, E, G, I highlight representative cases). At high-power magnification, E-cadherin staining showed specific membranous staining pattern (Figs. 1D, F, H, J) . Hematoxylin and eosinstained sections of cutaneous sarcoidosis demonstrated naked granulomas composed of epithelioid histiocytes and MNGCs ( Figs. 2A, B demonstrate a representative case). There was no foreign material observed in our cases of sarcoidosis by polarized microscopy. The E-cadherin staining pattern of mononuclear and multinuclear histiocytes was similar to the pattern in FBGR, with 21 (100%)/21 of the sarcoidal cases demonstrating specific membranous staining pattern for E-cadherin (Figs. 2C-J). Additionally, in both FBGR and sarcoidosis cases, MNGCs were rimmed by adherent E-cadherin-positive mononuclear cells ( Figs. 1, 2D , F, H, and J panels). The number of E-cadherin expressing mono-and multinucleated histiocytes varied among cases in both types of granulomas. Notably, granuloma-associated histiocytes did not stain with CD1a or AE1/AE3 immunostains (not shown). The specificity of the E-cadherin staining was further confirmed by negative staining with isotype-matched control antibody (not shown).
DISCUSSION
Histiocyte is originally a histological description referring to large phagocytic cells with abundant cytoplasm and one or more pale oval or kidney-shaped nuclei in secondary lymphoid organs. 16 Currently, we loosely use this term in reference to monocyte-derived tissue phagocytes that include macrophages and DCs. The boundaries of this term are further stretched by growing number of new phenotypic and functional subsets of tissue phagocytes. 17 The role of these new histiocyte subsets in human disease is poorly understood. Here, we demonstrate that significant number of E-cadherin expressing mononuclear histiocytes and MNGCs are present in 2 immunologically distinct cutaneous granulomas, FBGR and sarcoidosis.
E-cadherin expression has been previously described in several myeloid-derived innate phagocytes in mice, including LCs, AAMacs, AADCs, and IL-23 producing inflammatory DCs. The exact lineage derivation of the E-cadherin + mononuclear cells in cutaneous granulomas is currently unclear because of the lack of appropriate surface markers that could discriminate between various human macrophage and DC subsets. Nonetheless, the lack of CD1a staining on granulomaassociated histiocytes indicates that the E-cadherin + cells observed in this study are not LCs. The lack of staining for high molecular weight keratin (AE1/3) demonstrated that the E-cadherin expressing cells in granulomas are not epithelial in origin and not stained artifactually because of phagocytosed keratin debris. In mice, E-cadherin expressing AAMacs emerge on stimulation by IL-4 or IL-13 and have been associated with tissue remodeling and repair, and IL-4-dependent macrophage fusion. 7 Thus, E-cadherin expressing histiocytes could potentially correspond to AAMacs in foreign body granulomas (Fig. 3A) . As opposed to AAMacs, E-cadherin + AADCs maturing at inflammatory tissue foci from circulating monocytes are potent IL-12 producing cells that can augment IFN-g producing TH1 responses. 8 Thus, it is conceivable that in the early initiating phase of sarcoidal granuloma formation, an IL-4/IL-13-driven innate reaction composed of AADCs initiates and augments the characteristic TH1 milieu observed in well-formed sarcoidal granulomas (Fig. 3B ). Similar immune regulatory loops between TH1 and TH2 responses have been observed in infectious animal models. 18 Alternatively, the E-cadherin + mononuclear histiocytes in sarcoidal samples can represent IL-23 producing inflammatory DCs that had been described in a mouse model of inflammatory colitis. 15 These cells could potentiate a TH17 response that had been associated with sarcoidosis. 4, 10 Thus, E-cadherin + histiocytes in sarcoidosis could promote both TH1 and TH17 responses, which would synergistically activate IFN-g and IL-17Adependent myeloid fusion pathways leading to MNGC formation (Fig. 3B ). 19 The presence of E-cadherin expressing histiocytes rimming e-cadherin + MNGCs also suggests that E-cadherin + mononuclear cells correspond to fusogenic precursors for MNGCs in both FBGR and sarcoidosis (Figs. 3A, B) . The critical role for E-cadherin-dependent cell-cell adhesion in macrophage fusion also supports this notion. 13 Overall, our data suggest that E-cadherin expressing histiocytes may play an essential role in cutaneous granuloma formation. Because FBGR and sarcoidosis represent distinct immune processes, E-cadherin + histiocytes could be important in a broader spectrum of granulomatous reactions. Our ongoing efforts are aimed to assess the presence of these cells in both infectious and noninfectious granulomas, including granuloma annulare, necrobiosis lipoidica, and necrobiotic xanthogranuloma. Better understanding of the role of these innate cells in cutaneous granulomatous disorders may provide further understanding of the disease pathogenesis and could lead to alternative therapeutic interventions.
